Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 10,000 shares at $64.00 ($640K) on 2025-11-11, disclosed to the SEC on 2025-11-13.
Scheduled sale ($640k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVMD | SELL | 2026-06-18 | $425K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |